In order to determine whether glycolysis is increased in NeuroD2-SmoA1 medulloblastomas, we carried out immunostaining and western blot analysis of medulloblastomas and adjacent, non-tumorous cerebellum. This evidence concerns the gene NEUROD2 and medulloblastoma.